Dr John Philip Schwerkoske, MD in Chula Vista, CA - Medicare Hematology/oncology

Dr John Philip Schwerkoske, MD is a medicare enrolled "Internal Medicine - Hematology & Oncology" physician in Chula Vista, California. He went to Creighton University School Of Medicine and graduated in 2012 and has 12 years of diverse experience with area of expertise as Hematology/oncology. He is a member of the group practice The Oncology Institute Ca, A Professional Corporation and his current practice location is 450 4th Ave Ste 311, Chula Vista, California. You can reach out to his office (for appointments etc.) via phone at (619) 371-9156.

Dr John Philip Schwerkoske is licensed to practice in California (license number A136414) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1912260829.

Contact Information

	Dr John Philip Schwerkoske, MD
	450 4th Ave Ste 311, Chula Vista, CA 91910-4429
	(619) 371-9156
	Not Available

Physician's Profile

Full Name	Dr John Philip Schwerkoske
Gender	Male
Speciality	Hematology/oncology
Experience	12 Years
Location	450 4th Ave Ste 311, Chula Vista, California
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr John Philip Schwerkoske attended and graduated from Creighton University School Of Medicine in 2012

NPI Data:

NPI Number: 1912260829
Provider Enumeration Date: 06/17/2012
Last Update Date: 01/03/2022

Medicare PECOS Information:

PECOS PAC ID: 3577785153
Enrollment ID: I20180824001091

Medical Identifiers

Medical identifiers for Dr John Philip Schwerkoske such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1912260829	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RH0003X	Internal Medicine - Hematology & Oncology	A136414 (California)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
The Oncology Institute Ca, A Professional Corporation	5698872398	69

News Archive

Increased colorectal cancer screening in pre-Medicare population can reduce program costs

Investment in screening programs that target the pre-Medicare population, individuals aged between 50 and 64, is needed to reduce the costs of colorectal cancer in the Medicare program, according to the results of a new study, "Cost-Savings to Medicare from Increased Colorectal Cancer Screening in the Pre-Medicare Population," unveiled today at the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, Texas.

Study assesses post-coronary artery bypass graft surgery atrial fibrillation and long-term survival

Atrial fibrillation is a common complication of cardiac surgery, occurring in 10 percent to 40 percent of patients. Recent studies show it to be associated with poorer health following surgery and poorer long-term survival. Furthermore, development of atrial fibrillation after cardiac surgery leads to average additional health care costs of $15,000 to $20,000.

AiCure closes $12.25 million in Series A fundraising round

AiCure, an artificial intelligence company connecting the world's patients to better treatments and improved health, has closed a Series A fundraising round with $12.25 million. The consortium is led by New Leaf Venture Partners, with additional participation from Pritzker Group Venture Capital, Tribeca Venture Partners, and Biomatics Capital, established by Boris Nikolic, former Chief Advisor for Science and Technology to Bill Gates.

Bretuximab vedotin safe, effective for older Hodgkin lymphoma patients unfit for chemotherapy

A study, published online in Blood, the Journal of the American Society of Hematology, reports that bretuximab vedotin is an effective and safe first course of treatment for older Hodgkin lymphoma patients unfit for chemotherapy.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr John Philip Schwerkoske allows following entities to bill medicare on his behalf.

Entity Name	The Oncology Institute Ca, A Professional Corporation
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1275651515 PECOS PAC ID: 5698872398 Enrollment ID: O20070514000607

News Archive

Increased colorectal cancer screening in pre-Medicare population can reduce program costs

Study assesses post-coronary artery bypass graft surgery atrial fibrillation and long-term survival

AiCure closes $12.25 million in Series A fundraising round

Bretuximab vedotin safe, effective for older Hodgkin lymphoma patients unfit for chemotherapy

Entity Name	City Of Hope Medical Foundation
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1871886366 PECOS PAC ID: 3779751656 Enrollment ID: O20110720000244

Increased colorectal cancer screening in pre-Medicare population can reduce program costs

Study assesses post-coronary artery bypass graft surgery atrial fibrillation and long-term survival

AiCure closes $12.25 million in Series A fundraising round

Bretuximab vedotin safe, effective for older Hodgkin lymphoma patients unfit for chemotherapy

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr John Philip Schwerkoske is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr John Philip Schwerkoske, MD 18000 Studebaker Rd Ste 800, Cerritos, CA 90703-2671 Ph: (562) 735-3226	Dr John Philip Schwerkoske, MD 450 4th Ave Ste 311, Chula Vista, CA 91910-4429 Ph: (619) 371-9156

News Archive

Increased colorectal cancer screening in pre-Medicare population can reduce program costs

Study assesses post-coronary artery bypass graft surgery atrial fibrillation and long-term survival

AiCure closes $12.25 million in Series A fundraising round

Bretuximab vedotin safe, effective for older Hodgkin lymphoma patients unfit for chemotherapy

Internal Medicine Doctors in Chula Vista, CA

Dr. Perry V Montoya, M.D Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 525 3rd Ave, Chula Vista, CA 91910 Phone: 858-499-2600 Fax: 619-585-4353
John S Videen, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 752 Medical Center Ct, Suite 302, Chula Vista, CA 91911 Phone: 619-421-3361 Fax: 619-656-8936
Daniel Cepin, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 890 Eastlake Pkwy, Suite 205, Chula Vista, CA 91914 Phone: 619-482-0300 Fax: 619-482-0959
Kenneth Burton Johnson, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 769 Medical Center Ct, Suite 202, Chula Vista, CA 91911 Phone: 619-482-8430 Fax: 619-482-8005
Dr. Michael Sonbaty, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1400 E Palomar St, Chula Vista, CA 91913 Phone: 858-499-2616
Sara Khandan, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 835 Third Ave Ste A, Chula Vista, CA 91911 Phone: 619-425-7755 Fax: 619-425-2138
Alejandro G Hinojosa, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 340 4th Ave, Suite 8, Chula Vista, CA 91910 Phone: 619-216-7546 Fax: 619-216-7783

Dr John Philip Schwerkoske, MD - Medicare Hematology/oncology in Chula Vista, CA

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Increased colorectal cancer screening in pre-Medicare population can reduce program costs

Study assesses post-coronary artery bypass graft surgery atrial fibrillation and long-term survival

AiCure closes $12.25 million in Series A fundraising round

Bretuximab vedotin safe, effective for older Hodgkin lymphoma patients unfit for chemotherapy

Medicare Reassignments

Increased colorectal cancer screening in pre-Medicare population can reduce program costs

Study assesses post-coronary artery bypass graft surgery atrial fibrillation and long-term survival

AiCure closes $12.25 million in Series A fundraising round

Bretuximab vedotin safe, effective for older Hodgkin lymphoma patients unfit for chemotherapy

Increased colorectal cancer screening in pre-Medicare population can reduce program costs

Study assesses post-coronary artery bypass graft surgery atrial fibrillation and long-term survival

AiCure closes $12.25 million in Series A fundraising round

Bretuximab vedotin safe, effective for older Hodgkin lymphoma patients unfit for chemotherapy

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Increased colorectal cancer screening in pre-Medicare population can reduce program costs

Study assesses post-coronary artery bypass graft surgery atrial fibrillation and long-term survival

AiCure closes $12.25 million in Series A fundraising round

Bretuximab vedotin safe, effective for older Hodgkin lymphoma patients unfit for chemotherapy

Internal Medicine Doctors in Chula Vista, CA